Replies to post #310856 on Amarin Corp Plc (AMRN)

[Biobillionair]

Hikma is trying to kill 4118 cardiovascular patients by poisoning them with unregulated API. The API is unregulated because it doesn’t meet FDA RLD standards and the FDA doesn’t care.

BB

[Toddrobertking]

Yikes -10% on scripts this week....generics already eroding market share quickly

[Freifaller]

Sorry, even with the 4118 TRx of generic lovaza....why did we drop more then 10%? That means, we lost almost 10.000TRx? How is this possible?

[ziploc_1]

Amarin has recently been cash flow neutral...you don't have to be a soothsayer to tell that this situation is now definitely going to change ...legal strategies take time...at this time, Amarin needs to discontinue marketing strategies in favor of legal strategies...Amarin's legal case is just...but if it should fail, they would still have sufficient assets to be in a good position to fall back on their ROW strategy...as demonstrated by today's news from China...and soon to be demonstrated by EMA and EU approval of Vascepa.

[sstyles]

Maybe should have held off on posting scripts till after the market closed today to let the stock absorb this China news lol

oh well.

[iryokabu]

Script number looks bad, but is it really bad? Generics could steal only 5% share. IMO, WS might have thought that generics could steal much larger than that.

[circuitcity]

Thanks a lot, tuca. Fantastic data, we can see exactly what is going on in reality and don’t have to listen JT BS

[sts66]

TRx and NRx down -10% during a non-holiday week?!? That's really unusual. Have to watch this for another few weeks - it may be related to states going back to more stringent lock down orders because CV19 infection rates are soaring. My state walked most regs back close to where they were after they started lifting them, like only 25% capacity in stores, plus bars were closed again - not that that has any affect on V scrips. CA also just enacted a statewide curfew for something like 94% of the population - not allowed out of the house from 10 pm to 5 am.

[tucaman]

Scripts for week ending 11/20/2020
Below the updated script numbers. I included scripts for Lovaza (incl. Generic, though not sure I captured all suppliers) - for reference. I'll leave it to RAF and Sam to comment on plausibility of the figures.

Scripts taking another hit from generics, while the sales force is failing to grow the market. Disappointing to say the least.

Vascepa
TRx: 80'238 (-5.29%)
[I]NRx: 37'855 (-2.75%)

Generic Vascepa
TRx: 7'559 (+83.58%)
NRx: 4'118 (+69.56%)

Generic Lovaza
TRx: 62'833 (-1.69%)
NRx: 33'00 (-0.75%)